G3iii / 23B17: Describe the consequences for the left ventricle of a sudden and sustained increase in afterload

G1i / 23B02: Outline the anatomy of the cardiac ventricles including the chambers, valves and conduction elements

G7i / 23A20: Compare and contrast the relevant pharmacology of intravenous adrenaline andvasopressin

G7iii / 23A11: Outline the Vaughan Williams classification of anti-arhythmic drugs with examples (30% of Marks). Describe the relevant pharmacology of adenosine (70% of Marks)

G7i / 22B13: Compare and contrast the pharmacology of EPHEDRINE and METARAMINOL

G5i / 22B12: Describe the effects of ageing on the cardiovascular system

G2i / Eiii / 22B05: Outline the structure of fast cardiac sodium channels and describe in detail how they work

G7iii / 22A05: Write short notes on the pharmacology of labetalol and esmolol, highlighting their differences

G4vii / 21B13: Describe the factors that affect mixed venous oxygen saturation

G4vi / 22A20 / 20A07: Describe the physiological control of systemic vascular resistance (SVR)

G3vii / 17B19: Describe the physiology of a vasovagal syncope

G6iii / 19A08: Compare and contrast the measurement (40% of marks) and interpretation (60% of marks) of both central venous and mixed venous oxygen saturations

G1ii / 19B16: Compare the structure, function and coronary circulation of the right and left ventricles

G4vii / 17A19: Define mixed venous PO2 (20% of marks). Outline the factors that affect this value (80% of marks)

G7i / 21A01: Describe the pharmacology of adrenaline

G7i / 20B15: Compare and contrast the pharmacology of dobutamine and levosimendan

G5i / 20B11: Describe the changes in the circulatory system that occur during exercise.

G7ii: Classify antihypertensive agents by their MoA + Outline each mechanism briefly + Give an example of a drug from each class

G7iv: Define the MoA & AE of metoprolol & GTN when used to treat MI

G7ii: Pathophysiological basis for using ACEi + ARB in HF